Unlock AI-driven, actionable R&D insights for your next breakthrough.

L-Methionine Molecular Composition: Structural Characteristics, Synthesis Routes, And Applications In Pharmaceutical And Feed Industries

NOV 17, 202652 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
L-Methionine (C₅H₁₁NO₂S, molecular weight 149.21 g/mol) is an essential sulfur-containing amino acid characterized by a linear aliphatic side chain terminating in a thioether functional group. Its molecular composition comprises carbon, hydrogen, nitrogen, oxygen, and sulfur atoms arranged in a specific stereochemical configuration (L-enantiomer), which is critical for biological activity and distinguishes it from the racemic D,L-mixture produced via chemical synthesis 7. This article provides a comprehensive analysis of L-Methionine's molecular structure, compositional purity standards, synthesis methodologies, and industrial applications, targeting advanced R&D professionals engaged in amino acid biochemistry, pharmaceutical formulation, and animal nutrition.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Structure And Stereochemical Configuration Of L-Methionine

L-Methionine exists as the biologically active L-enantiomer, with the molecular formula C₅H₁₁NO₂S and a molecular weight of 149.21 g/mol 7. The molecule features a central α-carbon bonded to an amino group (-NH₂), a carboxyl group (-COOH), a hydrogen atom, and a side chain consisting of a two-carbon aliphatic segment (-CH₂-CH₂-) linked to a methylthio group (-S-CH₃) 3. This thioether functional group is the defining structural feature that enables L-Methionine to serve as a methyl donor precursor via conversion to S-adenosyl-L-methionine (SAM) 13.

The stereochemistry at the α-carbon is critical: only the L-configuration is recognized by mammalian enzymes such as S-adenosyltransferase, which catalyzes SAM formation 3. The D-enantiomer, while chemically similar, undergoes oxidative deamination by D-amino acid oxidase in the kidneys, generating hydrogen peroxide as a byproduct that may cause renal toxicity at elevated concentrations 11. Furthermore, D-methionine can competitively inhibit L-methionine metabolism by binding to S-adenosyltransferase without productive methyl transfer, thereby reducing methylation capacity 311. Consequently, pharmaceutical and feed-grade L-Methionine specifications mandate <2% D-methionine content to ensure efficacy and safety 1415.

Key structural parameters include:

  • Molecular geometry: Tetrahedral α-carbon with sp³ hybridization, enabling free rotation around C-C and C-S bonds in the side chain.
  • Functional groups: Primary amine (pKa ~9.2), carboxylic acid (pKa ~2.3), and thioether sulfur (non-ionizable under physiological pH).
  • Zwitterionic form: At physiological pH (7.4), L-Methionine exists predominantly as a zwitterion (NH₃⁺-CH(COO⁻)-R), conferring aqueous solubility (~56 g/L at 25°C) and crystalline stability 68.

Compositional Purity Standards And Analytical Characterization For L-Methionine

High-purity L-Methionine compositions are essential for pharmaceutical and feed applications, with purity thresholds typically exceeding 95% (w/w) 1415. Compositional analysis of industrial L-Methionine reveals the presence of minor co-products and residual process impurities, which must be quantified to meet regulatory standards (e.g., USP, EP, REACH).

Major And Minor Amino Acid Constituents

Fermentation-derived L-Methionine (e.g., via enzymatic conversion of O-acetylhomoserine) contains trace amounts of structurally related amino acids 689:

  • L-Phenylalanine: 0.05–5 wt%, arising from shared biosynthetic pathways in microbial fermentation 689.
  • L-Tyrosine: 0.01–3 wt%, co-produced during aromatic amino acid metabolism 689.
  • Glutamate: 0.01–11 wt%, a central metabolite in nitrogen assimilation 89.
  • Homoserine: 0.01–1 wt%, the immediate precursor in methionine biosynthesis 89.
  • O-Acetylhomoserine (OAHS): ≥1 ppb, a residual substrate from enzymatic synthesis 1415.

These impurities are typically removed via crystallization, yielding solid crude L-Methionine with 89–99.9 wt% purity 268. For example, a two-step crystallization process (primary and secondary crops) can elevate purity from 80–95 wt% to 95–99.9 wt% by recycling mother liquor and optimizing pH (4.0–5.5) and temperature (50°C) during activated carbon treatment 68.

Non-Amino Acid Impurities And Ionic Species

Industrial L-Methionine compositions also contain non-proteinogenic components 289:

  • Acetate: <2 wt%, derived from acetic acid used in enzymatic acetylation or pH adjustment 8910.
  • Sulfate: 0.2–0.3 wt%, introduced via sulfuric acid titration during crystallization 614.
  • Ammonium sulfate: 100–150 g/L in liquid formulations, serving as a nitrogen source and pH buffer 1415.
  • Carboxylic acids: 0.01–0.05 wt%, including residual organic acids from fermentation 14.
  • Lipids and sugars: <1 wt% each, remnants of microbial biomass 2.

Analytical techniques for compositional verification include:

  • High-performance liquid chromatography (HPLC): Quantifies L-Methionine and amino acid impurities with detection limits <0.01 wt% 68.
  • Ion chromatography (IC): Measures acetate, sulfate, and chloride concentrations 1415.
  • Radiocarbon (¹⁴C) analysis: Confirms bio-based carbon content (50–100%) in fermentation-derived L-Methionine, distinguishing it from petrochemical sources 10.
  • Optical rotation ([α]D²⁰): Verifies L-enantiomer purity; pure L-Methionine exhibits [α]D²⁰ = +21.5° (c = 2, 6 M HCl) 3.

Synthesis Routes And Production Methodologies For L-Methionine

L-Methionine is produced via three primary routes: chemical synthesis, microbial fermentation, and enzymatic bioconversion. Each method yields distinct compositional profiles and enantiomeric purities.

Chemical Synthesis And Enantiomer Separation

Chemical synthesis generates racemic D,L-methionine via Strecker reaction or hydantoin hydrolysis, requiring subsequent chiral resolution to isolate the L-enantiomer 37. For example:

  • Strecker synthesis: Reaction of 3-methylthiopropanal with ammonia and hydrogen cyanide, followed by hydrolysis, yields D,L-methionine 7.
  • Enantiomer separation: Enzymatic resolution using L-amino acid acylase or preferential crystallization of diastereomeric salts (e.g., with L-tartaric acid) enriches L-Methionine to >98% enantiomeric excess 37.

Drawbacks include high energy consumption, petrochemical feedstock dependence, and generation of D-methionine waste 7.

Microbial Fermentation And Metabolic Engineering

Fermentation employs genetically modified Escherichia coli or Corynebacterium glutamicum strains overexpressing methionine biosynthetic enzymes (e.g., homoserine O-acetyltransferase, cystathionine γ-synthase) 713. Key process parameters include:

  • Carbon source: Glucose or wheat hydrolysate (61.93 wt% in poultry feed formulations) 2.
  • Nitrogen source: Ammonium sulfate or soybean meal (16.20 wt%) 2.
  • Fermentation mode: Fed-batch culture with pH control (6.5–7.0) and dissolved oxygen >30% saturation 13.
  • Yield: 40–60 g/L L-Methionine in fermentation broth, with 80–95 wt% purity after crystallization 613.

Advantages include exclusive L-enantiomer production and renewable feedstock utilization, aligning with sustainability goals 710.

Enzymatic Bioconversion Of Precursors

A two-step enzymatic process converts O-acetylhomoserine (OAHS) to L-Methionine using methyl mercaptan (CH₃SH) and cystathionine β-lyase 71415:

  1. OAHS synthesis: Fermentation produces OAHS (119.12 g/mol) from glucose and acetate 1013.
  2. Thioether formation: Enzymatic addition of CH₃SH (48.11 g/mol) to OAHS yields L-Methionine (149.21 g/mol) and acetic acid (59.04 g/mol) 1014.

Reaction stoichiometry: OAHS (119.12 g/mol) - H₂O (18.01 g/mol) + CH₃SH (48.11 g/mol) → L-Methionine (149.21 g/mol) 10.

Process optimization includes:

  • Temperature: 30–40°C to maximize enzyme activity while minimizing thermal degradation 7.
  • pH: 7.0–8.0, maintained with phosphate buffer 14.
  • Substrate ratio: OAHS:CH₃SH molar ratio of 1:1.2 to drive reaction completion 7.
  • Crystallization: Cooling to 5–10°C and pH adjustment to 4.0–5.5 precipitates L-Methionine with >95% purity 68.

Mother liquor recycling recovers 40% residual methionine, improving overall yield to >90% 6.

Additive Formulations And Synergistic Compositions Containing L-Methionine

L-Methionine is frequently formulated with cofactors and vitamins to enhance bioavailability and metabolic efficacy, particularly in pharmaceutical and nutraceutical applications.

Magnesium Compounds For SAM Synthesis Enhancement

Magnesium ions (Mg²⁺) are essential cofactors for S-adenosyltransferase, the enzyme catalyzing L-Methionine conversion to SAM 13. Formulations include:

  • Magnesium chloride or carbonate: Mass ratio of Mg compound to L-Methionine = 1:2 to 1:6 1316.
  • Mechanism: Mg²⁺ stabilizes ATP binding in the enzyme active site, accelerating SAM formation 1.
  • Dosage: 20–70 mg L-Methionine/kg body mass/day, co-administered with 10–35 mg Mg²⁺/kg/day 13.

Magnesium carbonate is preferred for capsule formulations due to lower hygroscopicity compared to magnesium chloride 316.

B-Vitamin Cofactors For Homocysteine Remethylation

Folic acid, vitamin B₆ (pyridoxine), and vitamin B₁₂ (cobalamin) support the methionine cycle by facilitating homocysteine-to-methionine conversion 1316:

  • Folic acid: 0.7 µg–0.3 mg/kg/day; mass ratio to L-Methionine = 1:75 to 1:8000 1316.
  • Vitamin B₆: 0.1–1 mg/kg/day; mass ratio to L-Methionine = 1:60 to 1:3000 16.
  • Vitamin B₁₂: 0.001–0.01 mg/kg/day; mass ratio to L-Methionine = 1:3000 to 1:30000 13.

These additives reduce plasma homocysteine accumulation, mitigating cardiovascular risk and enhancing methylation capacity in subjects with chronic fatigue syndrome or immunodeficiency 116.

N-Acetyl-L-Methionine For Enhanced Stability

N-Acetyl-L-Methionine (molecular weight 191.25 g/mol) is synthesized by acetylating L-Methionine with acetic acid (42.04 g/mol after dehydration) 10. Compositional analysis reveals:

  • Bio-based carbon content: 50–100%, depending on acetylating enzyme source (fermentation-derived acetic acid increases bio-carbon to ≥75%) 10.
  • Stability: Acetylation protects the amino group from oxidative degradation, extending shelf life in feed formulations 10.
  • Bioavailability: Intestinal esterases hydrolyze N-acetyl-L-Methionine to release free L-Methionine, achieving equivalent bioactivity 10.

Applications Of L-Methionine Compositions In Pharmaceutical And Nutraceutical Sectors

L-Methionine's role as a methyl donor precursor and antioxidant substrate underpins diverse therapeutic applications.

Methylation Capacity Enhancement In Neurological Disorders

SAM, derived from L-Methionine, donates methyl groups for neurotransmitter synthesis (e.g., dopamine, serotonin) and phospholipid methylation in neuronal membranes 137. Clinical formulations deliver 1.5–5.0 g L-Methionine/day (equivalent to 20–70 mg/kg for a 70 kg adult) to treat:

  • Depression: SAM supplementation (400–1600 mg/day) alleviates symptoms by enhancing monoamine neurotransmitter levels 1.
  • Chronic fatigue syndrome: L-Methionine (50 mg/kg/day) with magnesium (25 mg/kg/day) and B-vitamins improves energy metabolism and reduces oxidative stress 16.

Hepatoprotection And Detoxification Support

L-Methionine is a precursor for glutathione (GSH), the primary intracellular antioxidant 7. Therapeutic applications include:

  • Acetaminophen overdose: L-Methionine (2.5 g orally within 10 hours) replenishes hepatic GSH, preventing liver necrosis 3.
  • Heavy metal chelation: Methionine-metal complexes (e.g., with lead, mercury) facilitate urinary excretion 14.

Immune System Modulation And Antiviral Activity

L-Methionine enhances T-cell proliferation and cytokine production via SAM-mediated DNA methylation 1. Dosages of 30–50 mg/kg/day are investigated for:

  • Immunodeficiency: Restoring lymphocyte function in HIV or cancer patients 1.
  • Viral infections: Inhibiting viral replication through methylation of viral RNA 1.

Applications Of L-Methionine Compositions In Animal Feed And Nutrition

L-Methionine is the first limiting amino acid in poultry and swine diets, critical for protein synthesis and growth performance.

Broiler Chicken Feed Formulations

Feed-grade L-Methionine (60–99.9 wt% purity) is supplemented at 0.05–0.25 wt% of total feed to achieve optimal growth rates 268. A representative broiler feed composition includes 2:

  • Wheat: 61.93 wt%
  • Cooked soybean: 16.20 wt%
  • Soybean oil cakes: 18.40 wt%
  • L-Methionine (solid crude, 89.49 wt% purity):
OrgApplication ScenariosProduct/ProjectTechnical Outcomes
BISSBORT SIEGBERT HEINRICH, DAVIS HENRY JOHNTreatment of immunodeficiency, viral infections, chronic fatigue syndrome, and neurological disorders requiring enhanced methylation capacity in human subjects.L-Methionine Pharmaceutical FormulationEnhanced methylation capacity with L-methionine (20-70 mg/kg/day) combined with magnesium compounds (mass ratio 1:2 to 1:6), folic acid (ratio 1:75 to 1:8000), vitamin B6 and B12 for S-adenosylmethionine synthesis and homocysteine remethylation.
Evonik Degussa GmbHBroiler chicken and poultry feed supplementation at 0.05-0.25 wt% to optimize growth performance as first limiting amino acid in animal nutrition.Fermentation-Derived L-Methionine Feed AdditiveSolid crude L-methionine with 89.49 wt% purity obtained via biomass bioconversion, containing controlled amino acid profile (L-phenylalanine 0.44%, L-tyrosine 0.44%) with mother liquor recycling achieving 40% residual methionine recovery.
CJ CHEILJEDANG CORPORATIONAnimal feed formulations for poultry and swine requiring essential amino acid supplementation with optimized bioavailability and compositional purity standards.High-Purity L-Methionine Feed CompositionFeed additive composition containing 60-99.9 wt% L-methionine with controlled impurities (L-phenylalanine 0.05-5 wt%, L-tyrosine 0.01-3 wt%, glutamate 0.01-11 wt%) achieved through two-step crystallization process elevating purity from 80-95 wt% to 95-99.9 wt%.
ARKEMA FRANCESustainable L-methionine production from renewable feedstocks for pharmaceutical and feed industries requiring high stereochemical purity without D-methionine contamination.Enzymatic L-Methionine Production ProcessTwo-step enzymatic bioconversion of O-acetylhomoserine (119.12 g/mol) with methyl mercaptan (48.11 g/mol) yielding exclusive L-enantiomer (>98% enantiomeric excess) with >90% overall yield through optimized temperature (30-40°C) and pH (7.0-8.0) control.
CJ CHEILJEDANG CORPORATIONFeed formulations requiring extended shelf-life amino acid supplementation with renewable carbon sourcing and protection against amino group oxidative degradation.Bio-Based N-Acetyl-L-MethionineN-Acetyl-L-Methionine (191.25 g/mol) with 50-100% bio-based carbon content derived from fermentation, providing enhanced oxidative stability and equivalent bioavailability through intestinal esterase hydrolysis to release free L-methionine.
Reference
  • Composition containing l-methionine and additives for use as a medicament
    PatentInactiveIL103152A
    View detail
  • Methionine-rich composition for feeding animals
    PatentActiveUS10440974B2
    View detail
  • Furth therapeutical uses of L-methionine and compositions
    PatentInactiveEP0532369A2
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png